Fort Sheridan Advisors LLC Oncocyte Corp Transaction History

Fort Sheridan Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	BUY	$2.04 - $3.59 $51,000 - $89,750	25,000 Added 22.73%	135,000 $293,000
Q3 2021 Nov 12, 2021	BUY	$3.53 - $5.89 $3,530 - $5,890	1,000 Added 0.92%	110,000 $392,000
Q2 2021 Aug 17, 2021	BUY	$3.77 - $6.0 $22,620 - $36,000	6,000 Added 5.83%	109,000 $626,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $246,170 - $669,500	103,000 New	103,000 $535,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $246M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Sheridan Advisors LLC with notifications on news.